Lipid-based Polyene Antifungal [EPC]

Lipid-based Polyene Antifungal [EPC] was reported 12863 times

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 INTERMITTENT POSITIVE PRESSURE BREATHING 10 0.7143
1 VASCULAR ANASTOMOTIC HAEMORRHAGE 20 0.6667
2 B SYMPTOMS 10 0.3846
3 BRONCHIAL ANASTOMOSIS COMPLICATION 9 0.3750
4 VENA CAVA INJURY 26 0.2826
5 PYELONEPHRITIS FUNGAL 17 0.2297
6 PROTOTHECOSIS 21 0.2234
7 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV 10 0.2222
8 PERINEAL CYST 16 0.2192
9 CHOROIDITIS 73 0.1952
10 FOETAL ANAEMIA 25 0.1908
11 HEPATOSPLENIC CANDIDIASIS 28 0.1905
12 DIAPHRAGMATIC INJURY 13 0.1757
13 GEOTRICHUM INFECTION 36 0.1706
14 DISSEMINATED MUCORMYCOSIS 65 0.1650
15 FUNGAL ENDOCARDITIS 48 0.1595
16 FUSARIUM INFECTION 111 0.1586
17 FUNGAL DISEASE CARRIER 16 0.1584
18 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 34 0.1466
19 ENDOCARDITIS CANDIDA 11 0.1447
20 DISSEMINATED COCCIDIOIDOMYCOSIS 20 0.1418
21 CEREBRAL ASPERGILLOSIS 87 0.1415
22 RHINOCEREBRAL MUCORMYCOSIS 49 0.1412
23 SERRATIA SEPSIS 15 0.1389
24 DISSEMINATED TRICHOSPORONOSIS 10 0.1389
25 TRICHOSPORON INFECTION 56 0.1383
26 OSTEOMYELITIS FUNGAL 23 0.1377
27 RENAL CYST HAEMORRHAGE 29 0.1283
28 INTRACRANIAL INFECTION 16 0.1280
29 BLOOD IMMUNOGLOBULIN M ABNORMAL 13 0.1262
30 SCEDOSPORIUM INFECTION 85 0.1204
31 MUCORMYCOSIS 306 0.1176
32 FLUOROSIS 10 0.1163
33 PULMONARY MUCORMYCOSIS 61 0.1155
34 SPLENIC EMBOLISM 13 0.1130
35 PERICORONITIS 10 0.1099
36 DISSEMINATED ASPERGILLOSIS 51 0.1081
37 PERINEPHRIC ABSCESS 16 0.1053
38 DISSEMINATED BLASTOMYCOSIS 18 0.1053
39 CONGENITAL PNEUMONIA 10 0.1053
40 MUCOCUTANEOUS LEISHMANIASIS 12 0.0984
41 DEHISCENCE 18 0.0952
42 LEISHMANIASIS 27 0.0931
43 ABSCESS FUNGAL 16 0.0914
44 MENINGITIS CRYPTOCOCCAL 159 0.0909
45 EYE INFECTION FUNGAL 35 0.0904
46 EMPHYSEMATOUS PYELONEPHRITIS 16 0.0874
47 VISCERAL LEISHMANIASIS 63 0.0873
48 KERATITIS FUNGAL 18 0.0865
49 SIDEROBLASTIC ANAEMIA 12 0.0857
50 CRYPTOCOCCAL MENINGOENCEPHALITIS 11 0.0840
51 DISSEMINATED CRYPTOCOCCOSIS 62 0.0819
52 URINARY TRACT CANDIDIASIS 15 0.0785
53 GASTROINTESTINAL MUCORMYCOSIS 13 0.0778
54 BLOOD IMMUNOGLOBULIN G ABNORMAL 13 0.0778
55 CRYPTOCOCCAL CUTANEOUS INFECTION 14 0.0769
56 CRYPTOCOCCOSIS 120 0.0736
57 FUNGAEMIA 115 0.0730
58 ABDOMINAL WALL HAEMORRHAGE 19 0.0728
59 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 22 0.0726
60 PARASPINAL ABSCESS 11 0.0710
61 CUTANEOUS MUCORMYCOSIS 13 0.0707
62 VARICELLA VIRUS TEST POSITIVE 12 0.0706
63 ADENOVIRUS REACTIVATION 10 0.0694
64 MYCOTIC ENDOPHTHALMITIS 13 0.0688
65 ASPERGILLOSIS 81 0.0620
66 ASPERGILLUS INFECTION 399 0.0607
67 GINGIVITIS ULCERATIVE 13 0.0605
68 SYSTEMIC MYCOSIS 70 0.0599
69 ZYGOMYCOSIS 28 0.0598
70 VASCULAR COMPRESSION 18 0.0570
71 CEREBRAL FUNGAL INFECTION 15 0.0530
72 PERIVENTRICULAR LEUKOMALACIA 15 0.0530
73 SYSTEMIC CANDIDA 124 0.0493
74 DELAYED GRAFT FUNCTION 35 0.0492
75 CANDIDA SEPSIS 44 0.0491
76 VITAMIN B1 DECREASED 12 0.0478
77 BLASTOMYCOSIS 23 0.0473
78 BRONCHOPULMONARY ASPERGILLOSIS 360 0.0464
79 CARDIAC VALVE VEGETATION 22 0.0453
80 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 15 0.0448
81 UREAPLASMA INFECTION 18 0.0441
82 PERIOSTITIS 19 0.0440
83 MORAXELLA INFECTION 12 0.0438
84 IDIOPATHIC PNEUMONIA SYNDROME 13 0.0436
85 IMMUNE RECONSTITUTION SYNDROME 55 0.0426
86 SEPTIC EMBOLUS 35 0.0421
87 HISTOPLASMOSIS DISSEMINATED 65 0.0409
88 FUNGAL SEPSIS 34 0.0409
89 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 9 0.0407
90 ASPERGILLOMA 13 0.0406
91 CNS VENTRICULITIS 13 0.0399
92 PNEUMONIA CRYPTOCOCCAL 37 0.0392
93 BLOOD BETA-D-GLUCAN INCREASED 12 0.0391
94 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 189 0.0379
95 EYE ABSCESS 11 0.0361
96 CITROBACTER INFECTION 15 0.0350
97 NECROTISING RETINITIS 22 0.0344
98 POSITIVE AIRWAY PRESSURE THERAPY 10 0.0342
99 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 12 0.0342
100 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 72 0.0338
101 INFECTION IN AN IMMUNOCOMPROMISED HOST 24 0.0334
102 LOWER RESPIRATORY TRACT INFECTION FUNGAL 13 0.0334
103 NEPHROGENIC DIABETES INSIPIDUS 38 0.0329
104 PULMONARY NECROSIS 11 0.0323
105 VESICOURETERIC REFLUX 13 0.0321
106 BLOOD URIC ACID ABNORMAL 13 0.0319
107 PHAEOHYPHOMYCOSIS 15 0.0313
108 SINUSITIS FUNGAL 25 0.0312
109 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 9 0.0310
110 CAROTID ARTERIOSCLEROSIS 31 0.0300
111 SERRATIA INFECTION 22 0.0295
112 ASPERGILLUS TEST POSITIVE 9 0.0292
113 BRAIN ABSCESS 72 0.0284
114 WHITE MATTER LESION 35 0.0277
115 DELIVERY 18 0.0273
116 PNEUMONIA FUNGAL 107 0.0271
117 ENGRAFTMENT SYNDROME 16 0.0271
118 SPLENIC LESION 10 0.0270
119 RESPIRATORY TRACT INFECTION FUNGAL 14 0.0265
120 LUNG TRANSPLANT REJECTION 17 0.0258
121 CENTRAL NERVOUS SYSTEM VASCULITIS 13 0.0255
122 INTERLEUKIN LEVEL INCREASED 14 0.0254
123 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 15 0.0250
124 INTERVERTEBRAL DISC SPACE NARROWING 20 0.0248
125 RETINAL ISCHAEMIA 15 0.0245
126 HEPATOSPLENOMEGALY 63 0.0245
127 STENOTROPHOMONAS INFECTION 33 0.0243
128 CORYNEBACTERIUM INFECTION 13 0.0243
129 INFECTIVE ANEURYSM 12 0.0242
130 MEDIASTINITIS 14 0.0241
131 RECTAL PROLAPSE 29 0.0240
132 HISTOPLASMOSIS 42 0.0237
133 BLOOD LACTATE DEHYDROGENASE ABNORMAL 16 0.0236
134 AORTIC DILATATION 26 0.0234
135 ACINETOBACTER INFECTION 25 0.0228
136 GRANULOMATOUS LIVER DISEASE 16 0.0227
137 COCCIDIOIDOMYCOSIS 27 0.0226
138 ENTEROCOCCAL INFECTION 109 0.0225
139 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 62 0.0224
140 PSEUDOMONAL SEPSIS 39 0.0222
141 ENDOPHTHALMITIS 132 0.0220
142 RENAL ABSCESS 18 0.0220
143 BRONCHOSTENOSIS 12 0.0219
144 CYTOMEGALOVIRUS ENTEROCOLITIS 16 0.0208
145 URINARY TRACT INFECTION ENTEROCOCCAL 19 0.0203
146 PNEUMONIA NECROTISING 13 0.0201
147 NEPHROPATHY TOXIC 224 0.0199
148 RENAL ARTERY STENOSIS 27 0.0196
149 GRAFT VERSUS HOST DISEASE IN LIVER 14 0.0196
150 FEBRILE INFECTION 23 0.0195
151 COAGULATION TEST ABNORMAL 15 0.0195
152 MULTIPLE ORGAN DYSFUNCTION SYNDROME 549 0.0194
153 MUSCLE ABSCESS 12 0.0193
154 MARROW HYPERPLASIA 13 0.0191
155 ENTEROCOCCAL BACTERAEMIA 20 0.0189
156 CHYLOTHORAX 13 0.0180
157 HYPOPROTEINAEMIA 34 0.0179
158 LIP EROSION 13 0.0178
159 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 14 0.0178
160 THYROXINE FREE DECREASED 10 0.0177
161 PSEUDOMONAL BACTERAEMIA 15 0.0176
162 CYTOMEGALOVIRUS TEST POSITIVE 31 0.0174
163 ABDOMINAL COMPARTMENT SYNDROME 11 0.0173
164 PULMONARY CAVITATION 15 0.0172
165 CHORIORETINITIS 11 0.0171
166 DYSBIOSIS 14 0.0171
167 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 24 0.0170
168 MYCOBACTERIAL INFECTION 29 0.0168
169 GRAFT VERSUS HOST DISEASE 121 0.0168
170 GRAFT VERSUS HOST DISEASE IN SKIN 37 0.0168
171 PULMONARY SEPSIS 24 0.0165
172 PATHOGEN RESISTANCE 149 0.0163
173 PNEUMONIA PSEUDOMONAL 25 0.0163
174 HAEMOPERITONEUM 13 0.0162
175 ACTINIC KERATOSIS 42 0.0162
176 CEREBRAL CYST 11 0.0160
177 PNEUMOCYSTIS JIROVECII INFECTION 19 0.0159
178 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 37 0.0158
179 STREPTOCOCCAL BACTERAEMIA 17 0.0156
180 TRACHEOBRONCHITIS 12 0.0156
181 VIRAL HAEMORRHAGIC CYSTITIS 11 0.0154
182 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 116 0.0154
183 CELLULITIS ORBITAL 9 0.0154
184 COMPLICATIONS OF TRANSPLANTED KIDNEY 35 0.0154
185 KLEBSIELLA INFECTION 78 0.0154
186 PULMONARY MYCOSIS 12 0.0154
187 INTESTINAL INFARCTION 14 0.0154
188 GRAFT COMPLICATION 9 0.0153
189 PROTEUS INFECTION 11 0.0153
190 METAPNEUMOVIRUS INFECTION 12 0.0153
191 RENAL TUBULAR DISORDER 43 0.0153
192 PNEUMONIA KLEBSIELLA 28 0.0152
193 VENOOCCLUSIVE DISEASE 38 0.0152
194 SYSTEMIC INFECTION 25 0.0151
195 LYMPHOCELE 10 0.0151
196 BRAIN HERNIATION 45 0.0151
197 BACTERIAL SEPSIS 49 0.0150
198 VARICELLA ZOSTER VIRUS INFECTION 31 0.0149
199 TOXOPLASMOSIS 16 0.0148
200 ENTEROCOCCAL SEPSIS 12 0.0148
201 INTRACRANIAL MASS 14 0.0148
202 PSEUDOMONAS TEST POSITIVE 12 0.0147
203 BACILLUS INFECTION 9 0.0142
204 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 47 0.0142
205 DRUG RESISTANCE 365 0.0142
206 NEUTROPENIC COLITIS 29 0.0140
207 BLADDER TRANSITIONAL CELL CARCINOMA 20 0.0140
208 CEREBRAL ARTERY EMBOLISM 17 0.0139
209 NECROTISING COLITIS 17 0.0134
210 CANDIDA INFECTION 226 0.0134
211 KLEBSIELLA SEPSIS 15 0.0133
212 SPLENIC INFARCTION 23 0.0132
213 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 35 0.0131
214 PULMONARY GRANULOMA 15 0.0131
215 ACUTE MYELOID LEUKAEMIA RECURRENT 28 0.0130
216 PSEUDOMONAS INFECTION 110 0.0128
217 STAPHYLOCOCCAL BACTERAEMIA 54 0.0124
218 FUNGAL SKIN INFECTION 50 0.0124
219 IMMUNOGLOBULINS DECREASED 17 0.0124
220 B-CELL TYPE ACUTE LEUKAEMIA 9 0.0123
221 CAPILLARY LEAK SYNDROME 25 0.0121
222 AORTIC ARTERIOSCLEROSIS 31 0.0120
223 ACUTE GRAFT VERSUS HOST DISEASE 55 0.0120
224 VENOOCCLUSIVE LIVER DISEASE 59 0.0119
225 MULTIPLE-DRUG RESISTANCE 37 0.0119
226 TUMOUR PSEUDOPROGRESSION 13 0.0119
227 INTRACRANIAL PRESSURE INCREASED 66 0.0118
228 HISTIOCYTOSIS HAEMATOPHAGIC 35 0.0118
229 TOXIC EPIDERMAL NECROLYSIS 178 0.0117
230 MEAN CELL VOLUME INCREASED 30 0.0117
231 NEUROLOGICAL DECOMPENSATION 27 0.0117
232 CHRONIC GRAFT VERSUS HOST DISEASE 42 0.0116
233 SOFT TISSUE INFECTION 21 0.0115
234 TRANSPLANT FAILURE 28 0.0114
235 DRUG LEVEL BELOW THERAPEUTIC 63 0.0114
236 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 15 0.0114
237 ADENOVIRUS INFECTION 33 0.0114
238 BK VIRUS INFECTION 38 0.0113
239 APLASIA 22 0.0112
240 HAEMOPHILUS INFECTION 11 0.0112
241 MUCOSAL HAEMORRHAGE 13 0.0112
242 HYPOFIBRINOGENAEMIA 11 0.0111
243 MUCOSAL DISORDER 11 0.0111
244 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 42 0.0110
245 APLASTIC ANAEMIA 57 0.0109
246 LEUKAEMIA RECURRENT 18 0.0106
247 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 101 0.0106
248 CYTOMEGALOVIRUS INFECTION 175 0.0105
249 INFECTIOUS PLEURAL EFFUSION 16 0.0105
250 PULMONARY HAEMORRHAGE 82 0.0105
251 RENAL ATROPHY 13 0.0104
252 HAEMATOLOGICAL INFECTION 25 0.0102
253 STREPTOCOCCAL SEPSIS 12 0.0101
254 SEPTIC SHOCK 436 0.0100
255 SECONDARY IMMUNODEFICIENCY 12 0.0099
256 NECROSIS 55 0.0099
257 MENINGITIS BACTERIAL 14 0.0098
258 CEREBRAL TOXOPLASMOSIS 9 0.0096
259 CYTOMEGALOVIRUS INFECTION REACTIVATION 42 0.0095
260 CYSTITIS HAEMORRHAGIC 38 0.0094
261 H1N1 INFLUENZA 13 0.0093
262 BRADYARRHYTHMIA 15 0.0091
263 SMALL INTESTINAL PERFORATION 17 0.0091
264 FUNGAL INFECTION 301 0.0090
265 INTERVERTEBRAL DISCITIS 17 0.0090
266 ENTEROBACTER INFECTION 15 0.0089
267 PNEUMONIA PNEUMOCOCCAL 13 0.0088
268 CENTRAL NERVOUS SYSTEM INFECTION 10 0.0087
269 GRANULOMA 30 0.0087
270 ESCHERICHIA INFECTION 70 0.0085
271 HYPOKALAEMIA 392 0.0085
272 CANDIDIASIS 34 0.0085
273 HUMAN HERPESVIRUS 6 INFECTION 16 0.0085
274 ACUTE LUNG INJURY 10 0.0084
275 DEVICE RELATED SEPSIS 17 0.0084
276 ENCEPHALITIS 58 0.0084
277 HAEMOTHORAX 24 0.0083
278 CYTOMEGALOVIRUS CHORIORETINITIS 16 0.0082
279 STAPHYLOCOCCAL SKIN INFECTION 10 0.0081
280 DISSEMINATED INTRAVASCULAR COAGULATION 114 0.0081
281 HYDROCEPHALUS 44 0.0081
282 ESCHERICHIA SEPSIS 23 0.0079
283 HYPERBILIRUBINAEMIA 82 0.0079
284 TRANSPLANT DYSFUNCTION 14 0.0078
285 ELECTROLYTE IMBALANCE 91 0.0078
286 SPINAL STENOSIS 32 0.0077
287 OLIGURIA 48 0.0077
288 LEFT VENTRICULAR HYPERTROPHY 33 0.0077
289 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 39 0.0077
290 LUNG ABSCESS 16 0.0076
291 OBLITERATIVE BRONCHIOLITIS 10 0.0076
292 TRANSPLANT REJECTION 61 0.0076
293 BONE MARROW TOXICITY 9 0.0076
294 LUNG CONSOLIDATION 21 0.0075
295 ACUTE ABDOMEN 11 0.0075
296 MULTI-ORGAN FAILURE 129 0.0075
297 BRAIN OEDEMA 93 0.0074
298 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
299 STEROID DIABETES 11 0.0073
300 STAPHYLOCOCCAL SEPSIS 36 0.0073
301 FEBRILE NEUTROPENIA 483 0.0073
302 PNEUMONIA CYTOMEGALOVIRAL 14 0.0072
303 HYPERAMMONAEMIA 36 0.0072
304 RHINOVIRUS INFECTION 28 0.0072
305 HYPERPARATHYROIDISM SECONDARY 18 0.0072
306 DIVERTICULUM INTESTINAL 31 0.0071
307 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 36 0.0071
308 INFLAMMATORY MARKER INCREASED 35 0.0071
309 EXOPHTHALMOS 15 0.0070
310 RETINITIS 12 0.0069
311 RENAL INFARCT 10 0.0069
312 NOSOCOMIAL INFECTION 15 0.0068
313 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 12 0.0068
314 SKIN NECROSIS 35 0.0067
315 AUTOIMMUNE HAEMOLYTIC ANAEMIA 23 0.0067
316 BLOOD CULTURE POSITIVE 20 0.0067
317 SUSPECTED OFF LABEL USE 30 0.0066
318 PNEUMOMEDIASTINUM 12 0.0066
319 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 17 0.0066
320 BACTERAEMIA 77 0.0065
321 BLADDER SPASM 12 0.0064
322 DERMATITIS EXFOLIATIVE 32 0.0064
323 MUCOSAL INFLAMMATION 167 0.0064
324 ESCHERICHIA URINARY TRACT INFECTION 27 0.0063
325 SQUAMOUS CELL CARCINOMA OF SKIN 38 0.0063
326 DRUG LEVEL INCREASED 104 0.0063
327 ACUTE RESPIRATORY DISTRESS SYNDROME 110 0.0062
328 DRUG LEVEL DECREASED 63 0.0062
329 LIVER ABSCESS 20 0.0062
330 BRAIN DEATH 19 0.0061
331 HEPATOTOXICITY 136 0.0061
332 CYTOMEGALOVIRUS VIRAEMIA 27 0.0061
333 ENDOCARDITIS 31 0.0060
334 IMPLANT SITE INFECTION 14 0.0060
335 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 329 0.0060
336 MIXED LIVER INJURY 18 0.0060
337 ESCHERICHIA BACTERAEMIA 14 0.0059
338 RESPIRATORY FAILURE 433 0.0059
339 STUPOR 19 0.0059
340 CLOSTRIDIUM TEST POSITIVE 13 0.0059
341 LUNG INFILTRATION 52 0.0059
342 PANCYTOPENIA 328 0.0059
343 HYPERPARATHYROIDISM 12 0.0058
344 CORNEAL OEDEMA 13 0.0058
345 UVEITIS 78 0.0057
346 LUNG OPACITY 15 0.0057
347 NEPHRITIS 19 0.0057
348 INHIBITORY DRUG INTERACTION 9 0.0057
349 IMPRISONMENT 10 0.0057
350 KIDNEY TRANSPLANT REJECTION 27 0.0056
351 PYELONEPHRITIS ACUTE 11 0.0056
352 MYCOBACTERIUM AVIUM COMPLEX INFECTION 15 0.0056
353 LIVER TRANSPLANT REJECTION 10 0.0056
354 BONE MARROW FAILURE 113 0.0056
355 MENINGITIS 37 0.0055
356 HERPES SIMPLEX 36 0.0055
357 EMPYEMA 11 0.0055
358 CENTRAL NERVOUS SYSTEM LESION 76 0.0055
359 OESOPHAGEAL CANDIDIASIS 22 0.0055
360 TORSADE DE POINTES 43 0.0055
361 SPLENOMEGALY 64 0.0055
362 LONG QT SYNDROME 13 0.0054
363 CEREBRAL HAEMATOMA 18 0.0054
364 HYPERTRANSAMINASAEMIA 37 0.0053
365 TACHYPNOEA 72 0.0053
366 PREMATURE DELIVERY 83 0.0052
367 NEUTROPENIC SEPSIS 37 0.0052
368 PNEUMONIA BACTERIAL 47 0.0051
369 ABDOMINAL INFECTION 13 0.0051
370 LEUKOPENIA 254 0.0051
371 HYPOGAMMAGLOBULINAEMIA 33 0.0050
372 HYPOALBUMINAEMIA 39 0.0050
373 ENCEPHALOPATHY 123 0.0050
374 ISCHAEMIA 23 0.0050
375 CEREBRAL VENOUS THROMBOSIS 9 0.0050
376 HEPATIC CYTOLYSIS 63 0.0049
377 AORTIC VALVE INCOMPETENCE 21 0.0049
378 INTRAOCULAR PRESSURE INCREASED 63 0.0049
379 PARADOXICAL DRUG REACTION 18 0.0049
380 SHOCK 112 0.0049
381 STREPTOCOCCAL INFECTION 27 0.0048
382 OTITIS MEDIA 16 0.0048
383 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
384 BLOOD CREATININE DECREASED 15 0.0048
385 PULSELESS ELECTRICAL ACTIVITY 20 0.0048
386 HEPATIC NECROSIS 18 0.0048
387 HYPOMAGNESAEMIA 66 0.0047
388 HAEMODYNAMIC INSTABILITY 36 0.0047
389 BILIRUBIN CONJUGATED INCREASED 11 0.0047
390 FEBRILE BONE MARROW APLASIA 20 0.0047
391 RENAL IMPAIRMENT 395 0.0047
392 HEPATIC FIBROSIS 16 0.0047
393 PAPILLOEDEMA 21 0.0046
394 HYPERCAPNIA 14 0.0046
395 RENAL TUBULAR ACIDOSIS 10 0.0046
396 COAGULOPATHY 76 0.0046
397 PNEUMATOSIS INTESTINALIS 13 0.0046
398 PATENT DUCTUS ARTERIOSUS 18 0.0045
399 PULMONARY MASS 67 0.0045
400 PNEUMOCYSTIS JIROVECI PNEUMONIA 10 0.0045
401 PULMONARY ALVEOLAR HAEMORRHAGE 25 0.0045
402 C-REACTIVE PROTEIN INCREASED 162 0.0044
403 INTRAVENTRICULAR HAEMORRHAGE 11 0.0044
404 STEM CELL TRANSPLANT 11 0.0044
405 NEUROTOXICITY 77 0.0044
406 SEPSIS 488 0.0044
407 DRUG LEVEL ABOVE THERAPEUTIC 20 0.0044
408 PANCREATITIS NECROTISING 10 0.0043
409 METABOLIC ENCEPHALOPATHY 13 0.0043
410 NOCARDIOSIS 11 0.0043
411 PNEUMOCYSTIS JIROVECII PNEUMONIA 43 0.0043
412 CHOLESTASIS 82 0.0043
413 BACTERIAL INFECTION 79 0.0042
414 GENERALISED OEDEMA 52 0.0042
415 HYPERPHOSPHATAEMIA 9 0.0042
416 RENAL TUBULAR NECROSIS 41 0.0042
417 HEPATOMEGALY 41 0.0042
418 HEPATITIS CHOLESTATIC 25 0.0041
419 ACUTE MYELOID LEUKAEMIA 64 0.0041
420 VENTRICULAR FIBRILLATION 45 0.0040
421 TREATMENT FAILURE 335 0.0040
422 LEUKOENCEPHALOPATHY 15 0.0040
423 HAEMOLYTIC ANAEMIA 36 0.0040
424 THROMBOTIC MICROANGIOPATHY 39 0.0040
425 VASCULAR DEVICE INFECTION 18 0.0040
426 IMMUNOSUPPRESSION 35 0.0040
427 THERAPY NON-RESPONDER 178 0.0040
428 HEMIPARESIS 67 0.0040
429 DRUG-INDUCED LIVER INJURY 124 0.0039
430 SERUM SICKNESS 11 0.0039
431 CHOLECYSTITIS 47 0.0039
432 GAMMA-GLUTAMYLTRANSFERASE INCREASED 87 0.0039
433 ENDOTRACHEAL INTUBATION 11 0.0039
434 BLOOD ALBUMIN DECREASED 31 0.0039
435 ACUTE LYMPHOCYTIC LEUKAEMIA 11 0.0039
436 STAPHYLOCOCCAL INFECTION 127 0.0038
437 ORGANISING PNEUMONIA 19 0.0038
438 GASTROINTESTINAL TOXICITY 18 0.0037
439 SKIN MASS 25 0.0037
440 HYPERLACTACIDAEMIA 10 0.0037
441 PNEUMOTHORAX 59 0.0037
442 PORTAL VEIN THROMBOSIS 12 0.0037
443 SHOCK HAEMORRHAGIC 30 0.0037
444 GASTRIC PERFORATION 10 0.0037
445 SPINAL OSTEOARTHRITIS 32 0.0036
446 PARTIAL SEIZURES 19 0.0036
447 ACUTE KIDNEY INJURY 553 0.0036
448 ORAL CANDIDIASIS 47 0.0036
449 CUTANEOUS VASCULITIS 13 0.0036
450 WOUND DEHISCENCE 12 0.0035
451 HYPERPYREXIA 15 0.0035
452 BLOOD CREATININE INCREASED 230 0.0035
453 PULMONARY TUBERCULOSIS 15 0.0035
454 STEVENS-JOHNSON SYNDROME 78 0.0035
455 METABOLIC ACIDOSIS 111 0.0035
456 LYMPHOPENIA 49 0.0035
457 ENTEROCOLITIS 20 0.0035
458 BREAST CANCER METASTATIC 37 0.0034
459 AUTOIMMUNE THYROIDITIS 13 0.0034
460 THROMBOPHLEBITIS 12 0.0034
461 LOW BIRTH WEIGHT BABY 27 0.0034
462 HEPATIC FAILURE 102 0.0034
463 NEUTROPENIA 456 0.0034
464 ARTERIOSCLEROSIS 31 0.0033
465 PURULENT DISCHARGE 14 0.0033
466 RESPIRATORY DISORDER 98 0.0033
467 CEREBRAL INFARCTION 80 0.0033
468 HEPATIC FUNCTION ABNORMAL 122 0.0033
469 RESPIRATORY DISTRESS 90 0.0033
470 BLOOD BILIRUBIN INCREASED 88 0.0033
471 MALABSORPTION 17 0.0033
472 HEPATIC LESION 14 0.0032
473 CIRCULATORY COLLAPSE 55 0.0032
474 ORGAN FAILURE 13 0.0032
475 SERUM FERRITIN INCREASED 17 0.0032
476 THROMBOCYTOPENIA 358 0.0032
477 DRUG INEFFECTIVE 4204 0.0032
478 SUBCUTANEOUS ABSCESS 15 0.0031
479 ATRIOVENTRICULAR BLOCK 24 0.0031
480 TRANSAMINASES INCREASED 69 0.0031
481 HAEMOPTYSIS 86 0.0031
482 ACUTE RESPIRATORY FAILURE 59 0.0031
483 PREMATURE BABY 92 0.0031
484 DEVICE RELATED INFECTION 47 0.0031
485 RESPIRATORY ACIDOSIS 12 0.0030
486 CYTOKINE RELEASE SYNDROME 61 0.0030
487 HYPERNATRAEMIA 15 0.0030
488 HEMIPLEGIA 25 0.0030
489 AZOTAEMIA 12 0.0030
490 DISEASE PROGRESSION 354 0.0030
491 PLEURAL EFFUSION 182 0.0030
492 HIV INFECTION 9 0.0030
493 ILEUS 37 0.0030
494 PARONYCHIA 13 0.0030
495 HYPERACUSIS 11 0.0030
496 HALLUCINATION, VISUAL 62 0.0029
497 PERIPHERAL SENSORY NEUROPATHY 17 0.0029
498 ANURIA 25 0.0029
499 HEPATOCELLULAR INJURY 41 0.0029
500 PERIORBITAL OEDEMA 15 0.0029
501 HYPERKALAEMIA 101 0.0029
502 SWELLING OF EYELID 18 0.0029
503 TYPE I HYPERSENSITIVITY 10 0.0028
504 ABSCESS 45 0.0028
505 UROSEPSIS 26 0.0028
506 ENTERITIS 18 0.0028
507 VITAMIN D DECREASED 24 0.0028
508 AGRANULOCYTOSIS 52 0.0028
509 VENTRICULAR SEPTAL DEFECT 16 0.0028
510 ASCITES 82 0.0028
511 RENAL CYST 22 0.0028
512 CONDITION AGGRAVATED 839 0.0028
513 PRODUCT PRESCRIBING ISSUE 60 0.0028
514 LARGE INTESTINE POLYP 19 0.0027
515 RASH MACULO-PAPULAR 61 0.0027
516 BLOOD ALKALINE PHOSPHATASE INCREASED 68 0.0027
517 SUPRAVENTRICULAR TACHYCARDIA 26 0.0027
518 CYTOLYTIC HEPATITIS 9 0.0027
519 VISUAL ACUITY REDUCED 90 0.0027
520 ACUTE HEPATIC FAILURE 37 0.0027
521 HYPOXIA 95 0.0027
522 ARTHRITIS BACTERIAL 11 0.0027
523 GENERAL PHYSICAL HEALTH DETERIORATION 310 0.0027
524 PANCREATITIS ACUTE 60 0.0027
525 BLOOD MAGNESIUM DECREASED 23 0.0027
526 LIVER FUNCTION TEST ABNORMAL 77 0.0026
527 CHOLECYSTITIS ACUTE 15 0.0026
528 RENAL FAILURE 348 0.0026
529 CYTOPENIA 32 0.0026
530 BLOOD POTASSIUM INCREASED 42 0.0026
531 ELECTROCARDIOGRAM QT PROLONGED 93 0.0026
532 PERFORMANCE STATUS DECREASED 12 0.0026
533 PNEUMONITIS 70 0.0026
534 ADRENAL INSUFFICIENCY 31 0.0026
535 BODY TEMPERATURE INCREASED 52 0.0025
536 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
537 RETINAL HAEMORRHAGE 18 0.0025
538 RENAL FAILURE ACUTE 107 0.0025
539 BLOOD UREA INCREASED 42 0.0025
540 ACUTE PULMONARY OEDEMA 14 0.0025
541 BLOOD CREATINE INCREASED 11 0.0025
542 DRUG INTERACTION 394 0.0025
543 GENERALISED TONIC-CLONIC SEIZURE 41 0.0025
544 CARDIOTOXICITY 22 0.0025
545 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 15 0.0025
546 ISCHAEMIC STROKE 44 0.0025
547 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
548 BASAL CELL CARCINOMA 38 0.0024
549 HYPERURICAEMIA 10 0.0024
550 HYPERCALCAEMIA 30 0.0024
551 SKIN LESION 66 0.0024
552 PYREXIA 824 0.0024
553 JAUNDICE 64 0.0024
554 HYPERTHYROIDISM 34 0.0023
555 POLYNEUROPATHY 28 0.0023
556 CACHEXIA 12 0.0023
557 HAEMOLYSIS 18 0.0023
558 CARDIOPULMONARY FAILURE 9 0.0023
559 PYELONEPHRITIS 20 0.0023
560 HYPOPHOSPHATAEMIA 17 0.0023
561 RESPIRATORY SYNCYTIAL VIRUS INFECTION 20 0.0023
562 HYPOVOLAEMIC SHOCK 11 0.0023
563 DRUG TOXICITY 31 0.0023
564 TOOTH INFECTION 30 0.0023
565 TUMOUR LYSIS SYNDROME 20 0.0023
566 HYDRONEPHROSIS 17 0.0023
567 CREATININE RENAL CLEARANCE DECREASED 9 0.0022
568 PRODUCT USE IN UNAPPROVED INDICATION 556 0.0022
569 VENTRICULAR TACHYCARDIA 37 0.0022
570 ILEUS PARALYTIC 10 0.0022
571 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 23 0.0022
572 ACIDOSIS 17 0.0022
573 LIPASE INCREASED 17 0.0022
574 BLOOD THYROID STIMULATING HORMONE DECREASED 10 0.0022
575 MYOPATHY 19 0.0022
576 UPPER GASTROINTESTINAL HAEMORRHAGE 37 0.0022
577 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 13 0.0022
578 ERYSIPELAS 11 0.0022
579 CEREBRAL ISCHAEMIA 11 0.0021
580 STATUS EPILEPTICUS 24 0.0021
581 SKIN TOXICITY 12 0.0021
582 PHOTOSENSITIVITY REACTION 35 0.0021
583 FACIAL PARALYSIS 18 0.0021
584 CARDIAC TAMPONADE 10 0.0021
585 CARDIAC FAILURE ACUTE 14 0.0021
586 OSTEOMYELITIS 38 0.0021
587 CHOLANGITIS 13 0.0021
588 HYPONATRAEMIA 118 0.0021
589 HEPATIC STEATOSIS 39 0.0021
590 MENTAL STATUS CHANGES 58 0.0021
591 BLOOD URIC ACID INCREASED 12 0.0021
592 SUBARACHNOID HAEMORRHAGE 21 0.0021
593 LUNG INFECTION 32 0.0021
594 PHOTOPSIA 13 0.0021
595 OFF LABEL USE 1800 0.0021
596 EMBOLISM 17 0.0020
597 DISEASE RECURRENCE 97 0.0020
598 CEREBRAL HAEMORRHAGE 73 0.0020
599 BLOOD POTASSIUM DECREASED 61 0.0020
600 AUTOIMMUNE HEPATITIS 14 0.0020
601 HEPATITIS ACUTE 13 0.0020
602 LIVER INJURY 49 0.0020
603 PULMONARY OEDEMA 89 0.0020
604 ALANINE AMINOTRANSFERASE INCREASED 121 0.0020
605 HYPOCALCAEMIA 37 0.0020
606 GRAND MAL CONVULSION 18 0.0019
607 PERICARDIAL EFFUSION 45 0.0019
608 MYELODYSPLASTIC SYNDROME 28 0.0019
609 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17 0.0019
610 HAEMODIALYSIS 16 0.0019
611 CARDIAC ARREST 157 0.0019
612 ANAEMIA 362 0.0019
613 RALES 11 0.0019
614 RESTLESSNESS 69 0.0019
615 ASPARTATE AMINOTRANSFERASE INCREASED 100 0.0019
616 MITRAL VALVE INCOMPETENCE 21 0.0019
617 GASTROENTERITIS 27 0.0018
618 EYE PAIN 104 0.0018
619 MYELOSUPPRESSION 66 0.0018
620 BLOOD LACTATE DEHYDROGENASE INCREASED 29 0.0018
621 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 47 0.0018
622 PURPURA 16 0.0018
623 SQUAMOUS CELL CARCINOMA 17 0.0018
624 VASCULITIS 21 0.0018
625 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
626 BLOOD PRESSURE FLUCTUATION 43 0.0018
627 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
628 HAEMATOTOXICITY 17 0.0018
629 METASTASES TO LYMPH NODES 12 0.0018
630 TACHYCARDIA 157 0.0018
631 NERVOUS SYSTEM DISORDER 55 0.0018
632 DIALYSIS 25 0.0018
633 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
634 DELIRIUM 61 0.0018
635 HAEMORRHAGE INTRACRANIAL 26 0.0017
636 BRADYCARDIA 92 0.0017
637 EPILEPSY 53 0.0017
638 LIVER DISORDER 76 0.0017
639 INFECTION 247 0.0017
640 PAPULE 12 0.0017
641 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 14 0.0017
642 HAEMORRHOIDS 33 0.0017
643 POLYP 11 0.0017
644 HYPOTHERMIA 17 0.0017
645 ODYNOPHAGIA 10 0.0017
646 THERAPY PARTIAL RESPONDER 26 0.0017
647 BEHAVIOUR DISORDER 9 0.0017
648 TYPE 1 DIABETES MELLITUS 10 0.0017
649 HEPATITIS B 10 0.0017
650 OPTIC NEURITIS 15 0.0016
651 FLUID OVERLOAD 24 0.0016
652 RED BLOOD CELL COUNT DECREASED 47 0.0016
653 NO THERAPEUTIC RESPONSE 20 0.0016
654 ORAL DISORDER 12 0.0016
655 MOUTH HAEMORRHAGE 12 0.0016
656 INTESTINAL ISCHAEMIA 9 0.0016
657 HYPERGLYCAEMIA 59 0.0016
658 RHINITIS 13 0.0016
659 COVID-19 PNEUMONIA 19 0.0016
660 RESTLESS LEGS SYNDROME 29 0.0016
661 HEPATIC ENZYME INCREASED 107 0.0016
662 HYPOTENSION 314 0.0016
663 HAEMATOCRIT DECREASED 31 0.0016
664 CARDIOMYOPATHY 23 0.0016
665 RENAL INJURY 46 0.0015
666 TUBULOINTERSTITIAL NEPHRITIS 29 0.0015
667 LIVER FUNCTION TEST INCREASED 33 0.0015
668 PULMONARY HYPERTENSION 32 0.0015
669 CARDIOGENIC SHOCK 22 0.0015
670 STOMATITIS 92 0.0015
671 ATAXIA 18 0.0015
672 HEPATIC ENCEPHALOPATHY 14 0.0015
673 POSTOPERATIVE WOUND INFECTION 10 0.0015
674 FOETAL GROWTH RESTRICTION 9 0.0015
675 IMMUNODEFICIENCY 22 0.0015
676 DEPRESSED LEVEL OF CONSCIOUSNESS 58 0.0015
677 HEPATITIS 37 0.0014
678 ANAPHYLACTIC SHOCK 37 0.0014
679 DIFFUSE LARGE B-CELL LYMPHOMA 11 0.0014
680 MUSCLE ATROPHY 18 0.0014
681 RETINAL DETACHMENT 13 0.0014
682 TREATMENT NONCOMPLIANCE 77 0.0014
683 PERITONITIS 29 0.0014
684 HAEMOGLOBIN DECREASED 143 0.0014
685 LYMPHADENOPATHY 49 0.0014
686 LEUKOCYTOSIS 25 0.0014
687 BLOOD SODIUM DECREASED 26 0.0014
688 LEUKAEMIA 13 0.0014
689 PNEUMONIA 445 0.0014
690 PRESYNCOPE 33 0.0014
691 CARDIO-RESPIRATORY ARREST 56 0.0013
692 ALTERED STATE OF CONSCIOUSNESS 29 0.0013
693 BLOOD CALCIUM DECREASED 15 0.0013
694 VITAMIN D DEFICIENCY 13 0.0013
695 BRONCHOSPASM 19 0.0013
696 ARRHYTHMIA 63 0.0013
697 ECCHYMOSIS 9 0.0013
698 HYPERTHERMIA 10 0.0013
699 MYOCARDITIS 15 0.0013
700 RESPIRATORY DEPRESSION 16 0.0013
701 EXPOSURE DURING PREGNANCY 81 0.0013
702 DRUG ERUPTION 23 0.0013
703 CONJUNCTIVITIS 24 0.0013
704 ANKYLOSING SPONDYLITIS 17 0.0013
705 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 10 0.0013
706 CHOLELITHIASIS 42 0.0013
707 SUBDURAL HAEMATOMA 18 0.0013
708 OXYGEN SATURATION DECREASED 70 0.0012
709 ATELECTASIS 12 0.0012
710 SKIN ULCER 32 0.0012
711 GLYCOSYLATED HAEMOGLOBIN INCREASED 31 0.0012
712 DECUBITUS ULCER 10 0.0012
713 COMA 58 0.0012
714 CEREBRAL DISORDER 9 0.0012
715 PROTEINURIA 23 0.0012
716 PNEUMONIA ASPIRATION 30 0.0012
717 MATERNAL EXPOSURE DURING PREGNANCY 107 0.0012
718 FOETAL EXPOSURE DURING PREGNANCY 97 0.0012
719 LUNG DISORDER 58 0.0012
720 CHILLS 138 0.0012
721 INTERSTITIAL LUNG DISEASE 57 0.0012
722 OBSTRUCTIVE AIRWAYS DISORDER 13 0.0012
723 SKIN HYPERPIGMENTATION 10 0.0012
724 SKIN INFECTION 13 0.0012
725 BLISTER 65 0.0012
726 CARDIAC MURMUR 10 0.0012
727 PRODUCT USE ISSUE 217 0.0012
728 NEUTROPHIL COUNT DECREASED 47 0.0012
729 NEURALGIA 28 0.0012
730 ATRIAL FIBRILLATION 112 0.0011
731 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
732 TRANSFUSION 12 0.0011
733 URINE OUTPUT DECREASED 10 0.0011
734 LACTIC ACIDOSIS 37 0.0011
735 EOSINOPHILIA 20 0.0011
736 CARDIOMEGALY 14 0.0011
737 LYMPHOCYTE COUNT DECREASED 20 0.0011
738 AUTOIMMUNE DISORDER 11 0.0011
739 BLOOD DISORDER 9 0.0011
740 MYOSITIS 10 0.0011
741 RESPIRATORY TRACT INFECTION 29 0.0011
742 RENAL DISORDER 51 0.0011
743 TOXIC SKIN ERUPTION 11 0.0011
744 HIATUS HERNIA 14 0.0011
745 EOSINOPHIL COUNT INCREASED 9 0.0011
746 MALNUTRITION 12 0.0011
747 CELLULITIS 54 0.0011
748 DIARRHOEA HAEMORRHAGIC 10 0.0011
749 VENTRICULAR EXTRASYSTOLES 11 0.0011
750 SINUS TACHYCARDIA 15 0.0011
751 FOLLICULITIS 11 0.0010
752 MOUTH ULCERATION 22 0.0010
753 PLATELET COUNT DECREASED 111 0.0010
754 CARDIAC FAILURE 83 0.0010
755 BLINDNESS 42 0.0010
756 TOXICITY TO VARIOUS AGENTS 173 0.0010
757 OEDEMA PERIPHERAL 125 0.0010
758 GASTROINTESTINAL HAEMORRHAGE 85 0.0010
759 OEDEMA 55 0.0010
760 ANOREXIA 13 0.0010
761 FEAR 27 0.0010
762 GASTROINTESTINAL DISORDER 89 0.0010
763 BLINDNESS UNILATERAL 14 0.0010
764 HERPES ZOSTER 57 0.0010
765 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 69 0.0010
766 ERYTHEMA MULTIFORME 9 0.0010
767 HAEMATURIA 33 0.0010
768 CYANOSIS 15 0.0010
769 INFLAMMATION 49 0.0009
770 PANCREATITIS 50 0.0009
771 OSTEONECROSIS 31 0.0009
772 METASTASES TO CENTRAL NERVOUS SYSTEM 12 0.0009
773 OESOPHAGITIS 10 0.0009
774 HYPOTONIA 9 0.0009
775 SWELLING FACE 58 0.0009
776 HYPOGLYCAEMIA 43 0.0009
777 HAEMORRHAGE 92 0.0009
778 INTENTIONAL PRODUCT USE ISSUE 77 0.0009
779 COLITIS 33 0.0009
780 VERTIGO 53 0.0009
781 MELAENA 19 0.0009
782 INFUSION RELATED REACTION 57 0.0009
783 WHITE BLOOD CELL COUNT DECREASED 93 0.0009
784 ACUTE MYOCARDIAL INFARCTION 25 0.0008
785 LYMPHOMA 13 0.0008
786 IMMUNE SYSTEM DISORDER 11 0.0008
787 RESPIRATORY ARREST 23 0.0008
788 HALLUCINATION, AUDITORY 13 0.0008
789 RASH PAPULAR 18 0.0008
790 DYSPHAGIA 75 0.0008
791 GASTRIC ULCER 15 0.0008
792 BLOOD TEST ABNORMAL 11 0.0008
793 HYPOPHAGIA 20 0.0008
794 FACE OEDEMA 13 0.0008
795 THROMBOSIS 62 0.0008
796 NODULE 10 0.0008
797 THERAPEUTIC RESPONSE DECREASED 46 0.0008
798 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 13 0.0008
799 DISORIENTATION 30 0.0008
800 DRUG INTOLERANCE 73 0.0008
801 SPINAL FRACTURE 15 0.0007
802 CLOSTRIDIUM DIFFICILE INFECTION 16 0.0007
803 DIPLOPIA 19 0.0007
804 HYPERTENSION 154 0.0007
805 CHRONIC KIDNEY DISEASE 55 0.0007
806 PRESCRIBED OVERDOSE 14 0.0007
807 CYSTITIS 23 0.0007
808 NIGHT SWEATS 23 0.0007
809 SKIN REACTION 10 0.0007
810 VOMITING 327 0.0007
811 RHABDOMYOLYSIS 29 0.0007
812 SINUSITIS 71 0.0007
813 URINARY RETENTION 23 0.0007
814 BRONCHITIS 51 0.0007
815 DEAFNESS 18 0.0007
816 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
817 HAEMATEMESIS 17 0.0007
818 DYSARTHRIA 25 0.0007
819 BLOOD PRESSURE DECREASED 44 0.0007
820 DEHYDRATION 88 0.0007
821 ANAPHYLACTIC REACTION 36 0.0007
822 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
823 PHOTOPHOBIA 12 0.0006
824 VIRAL INFECTION 21 0.0006
825 CARDIOVASCULAR DISORDER 16 0.0006
826 ANGINA PECTORIS 18 0.0006
827 ABDOMINAL PAIN 146 0.0006
828 HALLUCINATION 47 0.0006
829 HAEMATOMA 16 0.0006
830 PULMONARY EMBOLISM 58 0.0006
831 RASH ERYTHEMATOUS 29 0.0006
832 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
833 VISUAL IMPAIRMENT 74 0.0006
834 AGITATION 43 0.0006
835 TOOTH DISORDER 13 0.0006
836 MEDICATION ERROR 32 0.0006
837 SEIZURE 66 0.0006
838 GASTRITIS 15 0.0006
839 SWELLING 53 0.0006
840 EAR INFECTION 15 0.0006
841 ORAL HERPES 11 0.0006
842 CONVULSION 32 0.0006
843 GASTROENTERITIS VIRAL 10 0.0006
844 CONFUSIONAL STATE 89 0.0006
845 RASH MACULAR 19 0.0005
846 UNRESPONSIVE TO STIMULI 14 0.0005
847 DIVERTICULITIS 15 0.0005
848 SKIN DISORDER 18 0.0005
849 APHASIA 16 0.0005
850 DIABETES MELLITUS 40 0.0005
851 EPISTAXIS 39 0.0005
852 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
853 POST PROCEDURAL COMPLICATION 10 0.0005
854 PALLOR 14 0.0005
855 DEATH 438 0.0005
856 MALIGNANT NEOPLASM PROGRESSION 52 0.0005
857 INTESTINAL OBSTRUCTION 19 0.0005
858 COVID-19 87 0.0005
859 COUGH 139 0.0005
860 NEUROPATHY PERIPHERAL 47 0.0005
861 TASTE DISORDER 10 0.0005
862 DYSURIA 18 0.0005
863 DIARRHOEA 315 0.0005
864 CHROMATURIA 11 0.0005
865 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
866 HEPATIC CIRRHOSIS 9 0.0005
867 DECREASED APPETITE 111 0.0005
868 DERMATITIS 10 0.0005
869 DYSPNOEA 270 0.0005
870 DIABETIC KETOACIDOSIS 11 0.0005
871 WEIGHT DECREASED 127 0.0005
872 COGNITIVE DISORDER 21 0.0004
873 FEEDING DISORDER 9 0.0004
874 ERYTHEMA 91 0.0004
875 URINARY TRACT INFECTION 75 0.0004
876 HYPOTHYROIDISM 14 0.0004
877 NEOPLASM PROGRESSION 15 0.0004
878 HYPERSENSITIVITY 80 0.0004
879 SYNCOPE 43 0.0004
880 DRUG ADMINISTRATION ERROR 13 0.0004
881 NAUSEA 335 0.0004
882 OVERDOSE 88 0.0004
883 URINARY INCONTINENCE 12 0.0004
884 ECZEMA 21 0.0004
885 PRODUCTIVE COUGH 19 0.0004
886 HYPOACUSIS 17 0.0004
887 TREMOR 64 0.0004
888 LOSS OF CONSCIOUSNESS 49 0.0004
889 LETHARGY 22 0.0004
890 HAEMATOCHEZIA 21 0.0004
891 SKIN EXFOLIATION 32 0.0004
892 MUSCULAR WEAKNESS 43 0.0004
893 ABDOMINAL DISTENSION 39 0.0004
894 CARDIAC FAILURE CONGESTIVE 30 0.0004
895 DYSPNOEA EXERTIONAL 14 0.0004
896 WHEEZING 22 0.0004
897 NEPHROLITHIASIS 17 0.0004
898 CHEST PAIN 68 0.0004
899 EYE DISORDER 12 0.0004
900 SOMNOLENCE 73 0.0004
901 RASH 156 0.0004
902 ABDOMINAL PAIN LOWER 9 0.0004
903 SWOLLEN TONGUE 11 0.0004
904 HEADACHE 217 0.0003
905 BACK PAIN 80 0.0003
906 OSTEOPOROSIS 14 0.0003
907 LABORATORY TEST ABNORMAL 10 0.0003
908 IMPAIRED HEALING 11 0.0003
909 CONSTIPATION 73 0.0003
910 ILL-DEFINED DISORDER 20 0.0003
911 ACCIDENTAL OVERDOSE 12 0.0003
912 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
913 MYALGIA 53 0.0003
914 ABNORMAL BEHAVIOUR 12 0.0003
915 FLUSHING 30 0.0003
916 BONE PAIN 17 0.0003
917 RASH PRURITIC 15 0.0003
918 VISION BLURRED 38 0.0003
919 HEART RATE INCREASED 27 0.0003
920 GAIT INABILITY 9 0.0003
921 WEIGHT INCREASED 60 0.0003
922 INCORRECT DOSE ADMINISTERED 61 0.0003
923 DEEP VEIN THROMBOSIS 17 0.0003
924 HYPOAESTHESIA 39 0.0003
925 AGGRESSION 13 0.0003
926 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
927 CHEST DISCOMFORT 26 0.0003
928 OCULAR HYPERAEMIA 12 0.0003
929 INFLUENZA 28 0.0003
930 ANGIOEDEMA 11 0.0002
931 FLATULENCE 14 0.0002
932 POLLAKIURIA 10 0.0002
933 SKIN DISCOLOURATION 11 0.0002
934 OSTEOARTHRITIS 10 0.0002
935 CATARACT 14 0.0002
936 MUSCULOSKELETAL PAIN 12 0.0002
937 SLEEP DISORDER 16 0.0002
938 DISTURBANCE IN ATTENTION 12 0.0002
939 DYSPHONIA 13 0.0002
940 PRURITUS 85 0.0002
941 CEREBROVASCULAR ACCIDENT 37 0.0002
942 FLUID RETENTION 11 0.0002
943 DIZZINESS 107 0.0002
944 ASTHENIA 78 0.0002
945 FATIGUE 161 0.0002
946 UNDERDOSE 15 0.0002
947 CARDIAC DISORDER 19 0.0002
948 PAIN 122 0.0002
949 MYOCARDIAL INFARCTION 34 0.0002
950 HYPERHIDROSIS 25 0.0002
951 NO ADVERSE EVENT 34 0.0002
952 MALAISE 82 0.0002
953 RHINORRHOEA 12 0.0002
954 BALANCE DISORDER 16 0.0002
955 GAIT DISTURBANCE 35 0.0002
956 PRODUCT STORAGE ERROR 16 0.0002
957 PARAESTHESIA 28 0.0002
958 URTICARIA 29 0.0002
959 OROPHARYNGEAL PAIN 16 0.0002
960 ASTHMA 19 0.0002
961 IRRITABILITY 10 0.0002
962 INSOMNIA 44 0.0002
963 BLOOD PRESSURE INCREASED 25 0.0002
964 PAIN IN EXTREMITY 48 0.0002
965 PALPITATIONS 19 0.0002
966 ABDOMINAL PAIN UPPER 32 0.0002
967 FALL 50 0.0002
968 NEOPLASM MALIGNANT 10 0.0001
969 FEELING HOT 9 0.0001
970 DEPRESSION 31 0.0001
971 UNEVALUABLE EVENT 10 0.0001
972 ACNE 10 0.0001
973 ADVERSE EVENT 12 0.0001
974 DRY MOUTH 10 0.0001
975 DRUG ABUSE 10 0.0001
976 ARTHRALGIA 49 0.0001
977 MEMORY IMPAIRMENT 16 0.0001
978 ARTHRITIS 9 0.0001
979 MUSCULOSKELETAL STIFFNESS 10 0.0001
980 DYSPEPSIA 11 0.0001
981 BLOOD GLUCOSE INCREASED 21 0.0001
982 ADVERSE DRUG REACTION 10 0.0001
983 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
984 INTENTIONAL PRODUCT MISUSE 9 0.0001
985 ALOPECIA 18 0.0001
986 ANXIETY 26 0.0001
987 JOINT SWELLING 11 0.0001
988 PERIPHERAL SWELLING 14 0.0001
989 EMOTIONAL DISTRESS 10 0.0001
990 ABDOMINAL DISCOMFORT 13 0.0001
991 MUSCLE SPASMS 14 0.0001
992 NASOPHARYNGITIS 12 0.0001
993 PRODUCT DOSE OMISSION ISSUE 17 0.0001
994 FEELING ABNORMAL 12 0.0001